MentionFox
Home › funding signals › 1910
Accelerator · announced

1910 (YC W19) — Multimodal AI platform for modality agnostic drug Discovery™

We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.

1910 is a Y Combinator company in the Winter 2019 batch. Its directory entry describes it as: Multimodal AI Platform for Modality Agnostic Drug Discovery™. The founder listed is Jen Asher (Founder/CEO) (Y Combinator directory entry, March 23, 2021).

6 more companies from YC Winter 2019 ↓

Run the free check on 1910 →

Sell to companies like 1910? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

1910

New accelerator entry · 2021-03-23 · the record

Winter 2019
batch
20
people
Growth
stage
United States of America
region
Open the record →

What the record says

BatchWinter 2019
Announced2021-03-23
StageGrowth
StatusActive
Team size20
IndustryHealthcare
Sub-industryHealthcare -> Therapeutics
SectorsAI-powered Drug Discovery
RegionsUnited States of America, America / Canada
BasedBoston, MA, USA
HiringNo
Sitehttp://1910.ai
Previously known as1910 Genetics

Pitching, partnering or investing alongside them? See who really runs and owns 1910.

Free to see. No signup.

Keep reading

More on 1910 and the records around it.

Also in YC Winter 2019

Same batch, Healthcare first.

What do you want to do with 1910?

Get the full cited report on 1910

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on 1910: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.

Want the whole picture on 1910?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on 1910: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on 1910 covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind 1910: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for 1910. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups Drug discovery startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

1910: Accepted into Y Combinator Winter 2019
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-1910
Last updated 2026-10-20
Primary record: Y Combinator directory entry
1910 (YC W19) — Multimodal AI platform for modality agnostic drug Discovery™. MentionFox, 2026-10-20. https://mentionfox.com/funding/yc-1910